QPharma AB

Poland

All drugs from this manufacturer

  • ANAGRELID NORDIC

    This medicine is used to reduce an increased number of blood platelets (thrombocytes) in people with essential thrombocythemia. This helps to reduce the risk of circulatory and blood clotting problems.

    Dosage form: tablets

    Active substance Dosage
    anagrelide 0.75 mg

    ATC: L01XX35

  • This medicine is used to reduce an increased number of platelets (thrombocytes) in patients with essential thrombocythemia. This helps to reduce the risk of circulatory and blood clotting problems.

    Dosage form: tablets

    Active substance Dosage
    anagrelide 1 mg

    ATC: L01XX35

  • This medicine is used to reduce an increased number of blood platelets (thrombocytes) in people suffering from essential thrombocythemia. This helps to reduce the risk of circulatory and blood clotting problems.

    Dosage form: tablets

    Active substance Dosage
    anagrelide 0.5 mg

    ATC: L01XX35